nach oben

Erschienen in:

03.01.2022 | Special Contribution

International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs

verfasst von: Heidi W. Brown, Aparna Hegde, Markus Huebner, Hedwig Neels, Hayley C. Barnes, Gisele Vissoci Marquini, Narmin Mukhtarova, Bernard Mbwele, Visha Tailor, Ervin Kocjancic, Elisa Trowbridge, Lynsey Hayward

Erschienen in: International Urogynecology Journal | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

This narrative review describes the existing epidemiologic literature and identifies gaps regarding pelvic organ prolapse (POP) prevalence, incidence, natural history, and current and future service needs.

Materials and Methods

A PubMed search identified relevant citations published in 2000 or later. Pre-specified criteria were used to screen titles, abstracts, and manuscripts, including reference sections. Study findings were summarized to define what is known, identify gaps in current knowledge, and suggest priority areas for future research.

Results

The reported prevalence of POP varies widely (1–65%) based on whether its presence is ascertained by symptoms (1–31%), pelvic examination (10–50%), or both (20–65%). Most existing population-based surveys do not include physical examination data. White women from higher income countries are overrepresented in the existing literature. Incidence and natural history data are limited and consist mainly of cohorts that follow women after pregnancy or menopause. Given global increases in aging populations in well-resourced countries, the need for POP treatment is anticipated to increase in the coming decades. In lower and middle income countries (LMICs) where demographic trends are different, there is a dearth of information about anticipated POP service needs.

Conclusion

Future POP incidence, prevalence, and natural history studies should include non-white women from LMICs and should combine pelvic examination data with validated patient-reported outcome measures when feasible. Anticipated future service needs differ globally, with a greater demand for POP treatment services in well-resourced settings where aging populations are prevalent.

Akter F, Gartoulla P, Oldroyd J, Islam RM. Prevalence of, and risk factors for, symptomatic pelvic organ prolapse in Rural Bangladesh: a cross-sectional survey study. Int Urogynecol J. 2016;27(11):1753–9. https://doi.org/10.1007/s00192-016-3038-0.CrossRefPubMed

Awwad J, Sayegh R, Yeretzian J, Deeb ME. Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study. Menopause. 2012;19(11):1235–41. https://doi.org/10.1097/gme.0b013e31826d2d94.CrossRefPubMed

Ballard K, Ayenachew F, Wright J, Atnafu H. Prevalence of obstetric fistula and symptomatic pelvic organ prolapse in rural Ethiopia. Int Urogynecol J. 2016;27(7):1063–7. https://doi.org/10.1007/s00192-015-2933-0.CrossRefPubMed

Bland DR, Earle BB, Vitolins MZ, Burke G. Use of the pelvic organ prolapse staging system of the International Continence Society, American Urogynecologic Society, and Society of Gynecologic Surgeons in perimenopausal women. Am J Obstet Gynecol. 1999;181(6):1324–7; discussion 1327-1328. https://doi.org/10.1016/s0002-9378(99)70371-6.CrossRefPubMed

Bodner-Adler B, Shrivastava C, Bodner K. Risk factors for uterine prolapse in Nepal. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(11):1343–6. https://doi.org/10.1007/s00192-007-0331-y.CrossRefPubMed

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979-1997. Am J Obstet Gynecol. 2003;188(1):108–15. https://doi.org/10.1067/mob.2003.101.CrossRefPubMed

Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848–54. https://doi.org/10.1097/01.AOG.0000255977.91296.5d.CrossRefPubMed

Bradley CS, Zimmerman MB, Wang Q, Nygaard IE, Initiative WH. Vaginal descent and pelvic floor symptoms in postmenopausal women: a longitudinal study. Obstet Gynecol. 2008;111(5):1148–53. https://doi.org/10.1097/AOG.0b013e31816a3b96.CrossRefPubMed

Brown JS, Waetjen LE, Subak LL, Thom DH, Van den Eeden S, Vittinghoff E. Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol. 2002;186(4):712–6. https://doi.org/10.1067/mob.2002.121897.CrossRefPubMed

10.

Brown O, Mou T, Kenton K, Sheyn D, Bretschneider CE. Racial disparities in complications and costs after surgery for pelvic organ prolapse. Int Urogynecol J. 2021. https://doi.org/10.1007/s00192-021-04726-w.

11.

Brucker J, Wagner I, Rudofsky G, Rauch G, Sohn C, Brocker KA. In obesity even young women suffer from urogynecological symptoms. Arch Gynecol Obstet. 2017;296(5):947–56. https://doi.org/10.1007/s00404-017-4514-6.CrossRefPubMed

12.

Bump RC. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 1993;81(3):421–5.PubMed

13.

Chuenchompoonut V, Bunyavejchevin S, Wisawasukmongchol W, Taechakraichana N. Prevalence of genital prolapse in Thai menopausal women (using new standardization classification). J Med Assoc Thai. 2005;88(1):1–4.PubMed

14.

Cooper J, Annappa M, Dracocardos D, Cooper W, Muller S, Mallen C. Prevalence of genital prolapse symptoms in primary care: a cross-sectional survey. Int Urogynecol J. 2015;26(4):505–10. https://doi.org/10.1007/s00192-014-2556-x.CrossRefPubMed

15.

Coulibaly Y, Ouattara Z, Konate M, Sanogo M, Sinayogo B, Ouattara K. Cystocele: clinical and therapeutic aspects in the Urology Service of the Gabriel Toure University Hospital Center. Mali Med. 2010;25(2):29–31.PubMed

16.

Cundiff GW, Weidner AC, Visco AG, Bump RC, Addison WA. A survey of pessary use by members of the American urogynecologic society. Obstet Gynecol. 2000;95(6 Pt 1):931–5. https://doi.org/10.1016/s0029-7844(00)00788-2.CrossRefPubMed

17.

de Araujo MP, Takano CC, Girão MJ, Sartori MG. Pelvic floor disorders among indigenous women living in Xingu Indian Park, Brazil. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1079–84. https://doi.org/10.1007/s00192-009-0906-x.CrossRefPubMed

18.

Deeb ME, Awwad J, Yeretzian JS, Kaspar HG. Prevalence of reproductive tract infections, genital prolapse, and obesity in a rural community in Lebanon. Bull World Health Organ. 2003;81(9):639–45.PubMedPubMedCentral

19.

Diokno AC, Brown MB, Brock BM, Herzog AR, Normolle DP. Clinical and cystometric characteristics of continent and incontinent noninstitutionalized elderly. J Urol. 1988;140(3):567–71. https://doi.org/10.1016/s0022-5347(17)41720-4.CrossRefPubMed

20.

Elbiss HM, Osman N, Hammad FT. Prevalence, risk factors and severity of symptoms of pelvic organ prolapse among Emirati women. BMC Urol. 2015;15:66. https://doi.org/10.1186/s12894-015-0062-1.CrossRefPubMedPubMedCentral

21.

Elliott CS, Rhoads KF, Comiter CV, Chen B, Sokol ER. Improving the accuracy of prolapse and incontinence procedure epidemiology by utilizing both inpatient and outpatient data. Int Urogynecol J. 2013;24(11):1939–46. https://doi.org/10.1007/s00192-013-2113-z.CrossRefPubMed

22.

Eva UF, Gun W, Preben K. Prevalence of urinary and fecal incontinence and symptoms of genital prolapse in women. Acta Obstet Gynecol Scand. 2003;82(3):280–6. https://doi.org/10.1034/j.1600-0412.2003.00103.x.CrossRefPubMed

23.

Fialkow MF, Newton KM, Lentz GM, Weiss NS. Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(3):437–40. https://doi.org/10.1007/s00192-007-0459-9.CrossRefPubMed

24.

Fritel X, Varnoux N, Zins M, Breart G, Ringa V. Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol. 2009;113(3):609–16. https://doi.org/10.1097/AOG.0b013e3181985312.CrossRefPubMedPubMedCentral

25.

Garshasbi A, Faghih-Zadeh S, Falah N. The status of pelvic supporting organs in a population of iranian women 18 - 68 years of age and possible related factors. Arch Iran Med. 2006;9(2):124–8.PubMed

26.

Gedefaw G, Demis A. Burden of pelvic organ prolapse in Ethiopia: a systematic review and meta-analysis. BMC Womens Health. 2020;20(1):166. https://doi.org/10.1186/s12905-020-01039-w.CrossRefPubMedPubMedCentral

27.

Ghandour L, Minassian V, Al-Badr A, Abou Ghaida R, Geagea S, Bazi T. Prevalence and degree of bother of pelvic floor disorder symptoms among women from primary care and specialty clinics in Lebanon: an exploratory study. Int Urogynecol J. 2017;28(1):105–18. https://doi.org/10.1007/s00192-016-3080-y.CrossRefPubMed

28.

Gilchrist AS, Campbell W, Steele H, Brazell H, Foote J, Swift S. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse. Neurourol Urodyn. 2013;32(4):383–6. https://doi.org/10.1002/nau.22298.CrossRefPubMed

29.

Gomman HM, Nossier SA, Fotohi EM, Kholeif AE. Prevalence and factors associated with genital prolapse: a hospital-based study in Alexandria (Part I). J Egypt Public Health Assoc. 2001;76(5-6):313–35.PubMed

30.

Grodstein F, Fretts R, Lifford K, Resnick N, Curhan G. Association of age, race, and obstetric history with urinary symptoms among women in the Nurses' Health Study. Am J Obstet Gynecol. 2003;189(2):428–34. https://doi.org/10.1067/s0002-9378(03)00361-2.CrossRefPubMed

31.

Gumanga SK, Munkaila A, Malechi H. Social demographic characteristics of women with pelvic organ prolapse at the Tamale Teaching Hospital, Ghana. Ghana Med J. 2014;48(4):208–13. https://doi.org/10.4314/gmj.v48i4.7.CrossRefPubMedPubMedCentral

32.

Gyhagen M, Bullarbo M, Nielsen TF, Milsom I. Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG. 2013;120(2):152–60. https://doi.org/10.1111/1471-0528.12020.CrossRefPubMed

33.

Gyhagen M, Åkervall S, Milsom I. Clustering of pelvic floor disorders 20 years after one vaginal or one cesarean birth. Int Urogynecol J. 2015;26(8):1115–21. https://doi.org/10.1007/s00192-015-2663-3.CrossRefPubMed

34.

Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190(1):27–32. https://doi.org/10.1016/j.ajog.2003.07.017.CrossRefPubMed

35.

Handa VL, Blomquist JL, Roem J, Munoz A (2018) Longitudinal study of quantitative changes in pelvic organ support among parous women. Am J Obstet Gynecol 218 (3):320 e321-320 e327. https://doi.org/10.1016/j.ajog.2017.12.214

36.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26. https://doi.org/10.1007/s00192-009-0976-9.CrossRefPubMed

37.

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, Goldman HB, Huser M, Milani AL, Moran PA, Schaer GN, Withagen MI. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94. https://doi.org/10.1007/s00192-015-2932-1.CrossRefPubMed

38.

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, Goldman HB, Huser M, Milani AL, Moran PA, Schaer GN, Withagen MI. An International Urogynecological Association (IUGA) / International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Organ Prolapse (POP). Neurourol Urodyn. 2016;35(2):137–68. https://doi.org/10.1002/nau.22922.CrossRefPubMed

39.

Heit M, Rosenquist C, Culligan P, Graham C, Murphy M, Shott S. Predicting treatment choice for patients with pelvic organ prolapse. Obstet Gynecol. 2003;101(6):1279–84. https://doi.org/10.1016/s0029-7844(03)00359-4.CrossRefPubMed

40.

Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160–6. https://doi.org/10.1067/mob.2002.123819.CrossRefPubMed

41.

Henok A. Prevalence and Factors Associated with Pelvic Organ Prolapse among Pedestrian Back-Loading Women in Bench Maji Zone. Ethiop J Health Sci. 2017;27(3):263–72. https://doi.org/10.4314/ejhs.v27i3.8.CrossRefPubMedPubMedCentral

42.

Horst W, do Valle JB, Silva JC, CLL G. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J. 2017;28(8):1165–70. https://doi.org/10.1007/s00192-016-3238-7.CrossRefPubMed

43.

Huser M, Janku P, Hudecek R, Zbozinkova Z, Bursa M, Unzeitig V, Ventruba P. Pelvic floor dysfunction after vaginal and cesarean delivery among singleton primiparas. Int J Gynaecol Obstet. 2017;137(2):170–3. https://doi.org/10.1002/ijgo.12116.CrossRefPubMed

44.

Islam RM, Bell RJ, Billah B, Hossain MB, Davis SR. The prevalence of symptomatic pelvic floor disorders in women in Bangladesh. Climacteric. 2016;19(6):558–64. https://doi.org/10.1080/13697137.2016.1240771.CrossRefPubMed

45.

Islam RM, Oldroyd J, Rana J, Romero L, Karim MN. Prevalence of symptomatic pelvic floor disorders in community-dwelling women in low and middle-income countries: a systematic review and meta-analysis. Int Urogynecol J. 2019;30(12):2001–11. https://doi.org/10.1007/s00192-019-03992-z.CrossRefPubMed

46.

Jokhio AH, Rizvi RM, MacArthur C. Prevalence of pelvic organ prolapse in women, associated factors and impact on quality of life in rural Pakistan: population-based study. BMC Womens Health. 2020;20(1):82. https://doi.org/10.1186/s12905-020-00934-6.CrossRefPubMedPubMedCentral

47.

Kapoor DS, Meher S, Watkins L, Das M. Referral patterns for pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(12):1469–72. https://doi.org/10.1007/s00192-009-0972-0.CrossRefPubMed

48.

Kenton K, Mueller ER. The global burden of female pelvic floor disorders. BJU Int. 2006;98(Suppl 1):1–5; discussion 6-7. https://doi.org/10.1111/j.1464-410X.2006.06299.x.CrossRefPubMed

49.

Kirby AC, Luber KM, Menefee SA (2013) An update on the current and future demand for care of pelvic floor disorders in the United States. Am J Obstet Gynecol 209 (6):584.e581-585. https://doi.org/10.1016/j.ajog.2013.09.011

50.

Kudish BI, Iglesia CB, Sokol RJ, Cochrane B, Richter HE, Larson J, Hendrix SL, Howard BV. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol. 2009;113(1):81–8. https://doi.org/10.1097/AOG.0b013e318190a0dd.CrossRefPubMedPubMedCentral

51.

Kumari S, Walia I, Singh A. Self-reported uterine prolapse in a resettlement colony of north India. J Midwifery Womens Health. 2000;45(4):343–50. https://doi.org/10.1016/s1526-9523(00)00033-7.CrossRefPubMed

52.

Larsson C, Källen K, Andolf E (2009) Cesarean section and risk of pelvic organ prolapse: a nested case-control study. Am J Obstet Gynecol 200 (3):243.e241-244. https://doi.org/10.1016/j.ajog.2008.11.028

53.

Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol. 2008;111(3):678–85. https://doi.org/10.1097/AOG.0b013e3181660c1b.CrossRefPubMed

54.

Lien YS, Chen GD, Ng SC. Prevalence of and risk factors for pelvic organ prolapse and lower urinary tract symptoms among women in rural Nepal. Int J Gynaecol Obstet. 2012;119(2):185–8. https://doi.org/10.1016/j.ijgo.2012.05.031.CrossRefPubMed

55.

Løwenstein E, Ottesen B, Gimbel H. Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J. 2015;26(1):49–55. https://doi.org/10.1007/s00192-014-2413-y.CrossRefPubMed

56.

Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol. 2001;184(7):1496–501; discussion 1501-1493. https://doi.org/10.1067/mob.2001.114868.CrossRefPubMed

57.

Lukacz ES, Lawrence JM, Contreras R, Nager CW, Luber KM. Parity, mode of delivery, and pelvic floor disorders. Obstet Gynecol. 2006;107(6):1253–60. https://doi.org/10.1097/01.AOG.0000218096.54169.34.CrossRefPubMed

58.

Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol. 1997;104(5):579–85. https://doi.org/10.1111/j.1471-0528.1997.tb11536.x.CrossRefPubMed

59.

Marahatta RK, Shah A. Genital prolapse in women of Bhaktapur, Nepal. Nepal Med Coll J. 2003;5(1):31–3.PubMed

60.

Masenga GG, Shayo BC, Rasch V. Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community. PLoS One. 2018;13(4):e0195910. https://doi.org/10.1371/journal.pone.0195910.CrossRefPubMedPubMedCentral

61.

Mawajdeh SM, Al-Qutob RJ, Farag AM. Prevalence and risk factors of genital prolapse. A multicenter study. Saudi Med J. 2003;24(2):161–5.PubMed

62.

McLennan MT, Harris JK, Kariuki B, Meyer S. Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1063–9. https://doi.org/10.1007/s00192-008-0591-1.CrossRefPubMed

63.

Miedel A, Ek M, Tegerstedt G, Mæhle-Schmidt M, Nyrén O, Hammarström M. Short-term natural history in women with symptoms indicative of pelvic organ prolapse. Int Urogynecol J. 2011;22(4):461–8. https://doi.org/10.1007/s00192-010-1305-z.CrossRefPubMed

64.

Milsom I, Altman D, Lapitan MC, Nelson R, Sillen U, Thom D (2009) Epidemiology of urinary (UI) and faecal (FI) incontinence and pelvic organ prolapse (POP). Incontinence:35-111

65.

Mouritsen L, Larsen JP. Symptoms, bother and POPQ in women referred with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(2):122–7. https://doi.org/10.1007/s00192-002-1024-1.CrossRefPubMed

66.

Norton P, Brubaker L, Nager CW, Lemack GE, Zyczynski HM, Sirls L, Rickey L, Stoddard A, Varner RE, Network UIT (2014) Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence. Am J Obstet Gynecol 211 (5):550.e551-555. https://doi.org/10.1016/j.ajog.2014.07.053

67.

Nygaard I, Bradley C, Brandt D, Initiative WH. Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol. 2004;104(3):489–97. https://doi.org/10.1097/01.AOG.0000136100.10818.d8.CrossRefPubMed

68.

Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ, Network PFD. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6. https://doi.org/10.1001/jama.300.11.1311.CrossRefPubMedPubMedCentral

69.

Okonkwo JE, Obiechina NJ, Obionu CN. Incidence of pelvic organ prolapse in Nigerian women. J Natl Med Assoc. 2003;95(2):132–6.PubMedPubMedCentral

70.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501–6. https://doi.org/10.1016/S0029-7844(97)00058-6.CrossRefPubMed

71.

Ozel B, White T, Urwitz-Lane R, Minaglia S. The impact of pelvic organ prolapse on sexual function in women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(1):14–7. https://doi.org/10.1007/s00192-005-1327-0.CrossRefPubMed

72.

Pierce CB, Hallock JL, Blomquist JL, Handa VL. Longitudinal changes in pelvic organ support among parous women. Female Pelvic Med Reconstr Surg. 2012;18(4):227–32. https://doi.org/10.1097/SPV.0b013e3182626294.CrossRefPubMedPubMedCentral

73.

Pizarro-Berdichevsky J, Borazjani A, Pattillo A, Arellano M, Li J, Goldman HB. Natural history of pelvic organ prolapse in symptomatic patients actively seeking treatment. Int Urogynecol J. 2018;29(6):873–80. https://doi.org/10.1007/s00192-017-3450-0.CrossRefPubMed

74.

Rortveit G, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol. 2007;109(6):1396–403. https://doi.org/10.1097/01.AOG.0000263469.68106.90.CrossRefPubMed

75.

Scherf C, Morison L, Fiander A, Ekpo G, Walraven G. Epidemiology of pelvic organ prolapse in rural Gambia, West Africa. BJOG. 2002;109(4):431–6. https://doi.org/10.1111/j.1471-0528.2002.01109.x.CrossRefPubMed

76.

Seo JT, Kim JM. Pelvic organ support and prevalence by Pelvic Organ Prolapse-Quantification (POP-Q) in Korean women. J Urol. 2006;175(5):1769–72. https://doi.org/10.1016/S0022-5347(05)00993-6.CrossRefPubMed

77.

Sewell CA, Chang E, Sultana CJ. Prevalence of genital prolapse in 3 ethnic groups. J Reprod Med. 2007;52(9):769–73.PubMed

78.

Shah AD, Kohli N, Rajan SS, Hoyte L. The age distribution, rates, and types of surgery for pelvic organ prolapse in the USA. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(3):421–8. https://doi.org/10.1007/s00192-007-0457-y.CrossRefPubMed

79.

Shrestha B, Onta S, Choulagai B, Paudel R, Petzold M, Krettek A. Uterine prolapse and its impact on quality of life in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Bhaktapur, Nepal. Glob Health Action. 2015;8:28771. https://doi.org/10.3402/gha.v8.28771.CrossRefPubMed

80.

Slieker-ten Hove MC, Pool-Goudzwaard AL, Eijkemans MJ, Steegers-Theunissen RP, Burger CW, Vierhout ME. The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(9):1037–45. https://doi.org/10.1007/s00192-009-0902-1.CrossRefPubMedPubMedCentral

81.

Slieker-ten Hove MC, Pool-Goudzwaard AL, Eijkemans MJ, Steegers-Theunissen RP, Burger CW, Vierhout ME (2009) Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol 200 (2):184.e181-187. https://doi.org/10.1016/j.ajog.2008.08.070

82.

Smith FJ, Holman CD, Moorin RE, Tsokos N. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol. 2010;116(5):1096–100. https://doi.org/10.1097/AOG.0b013e3181f73729.CrossRefPubMed

83.

Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98(4):646–51. https://doi.org/10.1016/s0029-7844(01)01472-7.CrossRefPubMed

84.

Subramanian D, Szwarcensztein K, Mauskopf JA, Slack MC. Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and England. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):177–81. https://doi.org/10.1016/j.ejogrb.2009.03.004.CrossRefPubMed

85.

Sung VW, Raker CA, Myers DL, Clark MA (2009) Ambulatory care related to female pelvic floor disorders in the United States, 1995-2006. Am J Obstet Gynecol 201 (5):508.e501-506. https://doi.org/10.1016/j.ajog.2009.06.016

86.

Swift S, Woodman P, O'Boyle A, Kahn M, Valley M, Bland D, Wang W, Schaffer J. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192(3):795–806. https://doi.org/10.1016/j.ajog.2004.10.602.CrossRefPubMed

87.

Tegerstedt G, Miedel A, Maehle-Schmidt M, Nyren O, Hammarström M. A short-form questionnaire identified genital organ prolapse. J Clin Epidemiol. 2005;58(1):41–6. https://doi.org/10.1016/j.jclinepi.2004.06.008.CrossRefPubMed

88.

Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M. Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(6):497–503. https://doi.org/10.1007/s00192-005-1326-1.CrossRefPubMed

89.

Thompson JR, Chen AH, Pettit PD, Bridges MD. Incidence of occult rectal prolapse in patients with clinical rectoceles and defecatory dysfunction. Am J Obstet Gynecol. 2002;187(6):1494–9; discussion 1499-1500. https://doi.org/10.1067/mob.2002.129162.CrossRefPubMed

90.

Trutnovsky G, Kamisan Atan I, Martin A, Dietz HP. Delivery mode and pelvic organ prolapse: a retrospective observational study. BJOG. 2016;123(9):1551–6. https://doi.org/10.1111/1471-0528.13692.CrossRefPubMed

91.

Volløyhaug I, Mørkved S, Salvesen Ø, Salvesen K. Pelvic organ prolapse and incontinence 15-23 years after first delivery: a cross-sectional study. BJOG. 2015;122(7):964–71. https://doi.org/10.1111/1471-0528.13322.CrossRefPubMed

92.

Volløyhaug I, Mørkved S, Salvesen K. Association between pelvic floor muscle trauma and pelvic organ prolapse 20 years after delivery. Int Urogynecol J. 2016;27(1):39–45. https://doi.org/10.1007/s00192-015-2784-8.CrossRefPubMed

93.

Walker GJ, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int Urogynecol J. 2011;22(2):127–35. https://doi.org/10.1007/s00192-010-1215-0.CrossRefPubMed

94.

Whitcomb EL, Rortveit G, Brown JS, Creasman JM, Thom DH, Van Den Eeden SK, Subak LL. Racial differences in pelvic organ prolapse. Obstet Gynecol. 2009;114(6):1271–7. https://doi.org/10.1097/AOG.0b013e3181bf9cc8.CrossRefPubMedPubMedCentral

95.

Whitcomb EL, Lukacz ES, Lawrence JM, Nager CW, Luber KM. Prevalence and degree of bother from pelvic floor disorders in obese women. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(3):289–94. https://doi.org/10.1007/s00192-008-0765-x.CrossRefPubMed

96.

Woodman PJ, Swift SE, O'Boyle AL, Valley MT, Bland DR, Kahn MA, Schaffer JI. Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter cross-sectional study. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17(4):340–5. https://doi.org/10.1007/s00192-005-0009-2.CrossRefPubMed

97.

Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol. 2009;114(6):1278–83. https://doi.org/10.1097/AOG.0b013e3181c2ce96.CrossRefPubMed

98.

Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014;123(1):141–8. https://doi.org/10.1097/AOG.0000000000000057.CrossRefPubMedPubMedCentral

99.

Yuk JS, Lee JH, Hur JY, Shin JH. The prevalence and treatment pattern of clinically diagnosed pelvic organ prolapse: a Korean National Health Insurance Database-based cross-sectional study 2009-2015. Sci Rep. 2018;8(1):1334. https://doi.org/10.1038/s41598-018-19692-5.CrossRefPubMedPubMedCentral

100.

Zeleke BM, Bell RJ, Billah B, Davis SR. Symptomatic pelvic floor disorders in community-dwelling older Australian women. Maturitas. 2016;85:34–41. https://doi.org/10.1016/j.maturitas.2015.12.012.CrossRefPubMed

Titel: International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs
verfasst von: Heidi W. Brown
Aparna Hegde
Markus Huebner
Hedwig Neels
Hayley C. Barnes
Gisele Vissoci Marquini
Narmin Mukhtarova
Bernard Mbwele
Visha Tailor
Ervin Kocjancic
Elisa Trowbridge
Lynsey Hayward
Publikationsdatum: 03.01.2022
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 2/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-05018-z

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs

Abstract

Introduction and hypothesis

Materials and Methods

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Update Gynäkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Introduction and hypothesis

Materials and Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Modified vaginal hysterectomy for chronic non-puerperal complete uterine inversion: video presentation

Laparoscopic lateral suspension for anterior and apical prolapse: a prospective cohort with standardized technique

International Urogynaecology Consultation chapter 1 committee 4: patients’ perception of disease burden of pelvic organ prolapse

Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse

Abdominal pressure and pelvic organ prolapse: is there an association?

Development of a multinational, multidisciplinary competency framework for physiotherapy training in pessary management: an E-Delphi study

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Blutdrucksenkung könnte Uterusmyome verhindern

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

Update Gynäkologie